The American Journal of Managed Care1d
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) ...
New program for patients suffering from pulmonary hypertension
A new program in the Central Valley is now offering much-needed treatments for patients suffering from an advanced form of lung disease called pulmonary ...
Pulmonary Hypertension News1d
New tool helps predict lung disease-related PH mortality risk
Researchers developed a tool for predicting the prognosis of people with chronic lung disease-related pulmonary hypertension.
The American Journal of Managed Care4d
Managing Pulmonary Hypertension in Pregnancy
Pulmonary arterial hypertension (PAH) can be a challenging complication to manage during pregnancy; women with PAH who are ...
AHA/ASA Journals3d
Disparities in Current Pulmonary Embolism Management and Outcomes: A Scientific Statement From the American Heart Association
Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism ...
Hosted on MSN29d
Medications for Pulmonary Arterial Hypertension
Pulmonary hypertension (PH) can be challenging for healthcare professionals to diagnose because of its vague symptoms, such as fatigue and shortness of breath. These symptoms, which may be mild ...
Pulmonary Hypertension News8d
MTMR7 protein shows promise as PAH treatment in mice
Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...
Pulmonary Arterial Hypertension Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...